Evaluation of a combined drug-delivery system for proteins assembled with polymeric nanoparticles and porous microspheres; characterization and protein integrity studies
- PMID: 25936624
- DOI: 10.1016/j.ijpharm.2015.04.074
Evaluation of a combined drug-delivery system for proteins assembled with polymeric nanoparticles and porous microspheres; characterization and protein integrity studies
Abstract
This work presents an evaluation of the adsorption/infiltration process in relation to the loading of a model protein, α-amylase, into an assembled biodegradable polymeric system, free of organic solvents and made up of poly(D,L-lactide-co-glycolide) acid (PLGA). Systems were assembled in a friendly aqueous medium by adsorbing and infiltrating polymeric nanoparticles into porous microspheres. These assembled systems are able to load therapeutic amounts of the drug through adsorption of the protein onto the large surface area characteristic of polymeric nanoparticles. The subsequent infiltration of nanoparticles adsorbed with the protein into porous microspheres enabled the controlled release of the protein as a function of the amount of infiltrated nanoparticles, since the surface area available on the porous structure is saturated at different levels, thus modifying the protein release rate. Findings were confirmed by both the BET technique (N2 isotherms) and in vitro release studies. During the adsorption process, the pH of the medium plays an important role by creating an environment that favors adsorption between the surfaces of the micro- and nano-structures and the protein. Finally, assays of α-amylase activity using 2-chloro-4-nitrophenyl-α-D-maltotrioside (CNP-G3) as the substrate and the circular dichroism technique confirmed that when this new approach was used no conformational changes were observed in the protein after release.
Keywords: 2-Chloro-4-nitrophenyl-α-d-maltotrioside (PubChem CID: 9939545); Adsorption/infiltration; Poly(d,l-lactide-co-glycolide) acid (PubChem CID: 23111554); Polymeric nanoparticles; Porous microspheres; Protein delivery; Protein formulation.
Copyright © 2015 Elsevier B.V. All rights reserved.
Similar articles
-
A biodegradable polymeric system for peptide-protein delivery assembled with porous microspheres and nanoparticles, using an adsorption/infiltration process.Int J Nanomedicine. 2013;8:2141-51. doi: 10.2147/IJN.S44482. Epub 2013 Jun 10. Int J Nanomedicine. 2013. PMID: 23788833 Free PMC article.
-
Entrapment of protein using electrosprayed poly(D,L-lactide-co-glycolide) microspheres with a porous structure for sustained release.Macromol Rapid Commun. 2014 Jun;35(11):1033-8. doi: 10.1002/marc.201400042. Epub 2014 Apr 4. Macromol Rapid Commun. 2014. PMID: 24700776
-
Nanoparticle infiltration to prepare solvent-free controlled drug delivery systems.Int J Pharm. 2009 Apr 17;371(1-2):177-81. doi: 10.1016/j.ijpharm.2008.12.024. Epub 2008 Dec 27. Int J Pharm. 2009. PMID: 19150491
-
Overview of the preparation of organic polymeric nanoparticles for drug delivery based on gelatine, chitosan, poly(d,l-lactide-co-glycolic acid) and polyalkylcyanoacrylate.Colloids Surf B Biointerfaces. 2014 Jun 1;118:154-63. doi: 10.1016/j.colsurfb.2014.03.017. Epub 2014 Apr 1. Colloids Surf B Biointerfaces. 2014. PMID: 24769392 Review.
-
Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives.J Control Release. 2008 Feb 11;125(3):193-209. doi: 10.1016/j.jconrel.2007.09.013. Epub 2007 Oct 22. J Control Release. 2008. PMID: 18083265 Review.
Cited by
-
Insulin-loaded PLGA microspheres for glucose-responsive release.Drug Deliv. 2017 Nov;24(1):1513-1525. doi: 10.1080/10717544.2017.1381200. Drug Deliv. 2017. PMID: 28975813 Free PMC article.
-
Nanoparticles as Carriers of Proteins, Peptides and Other Therapeutic Molecules.Open Life Sci. 2018 Oct 31;13:285-298. doi: 10.1515/biol-2018-0035. eCollection 2018 Jan. Open Life Sci. 2018. PMID: 33817095 Free PMC article.
-
Encapsulation of Pharmaceutical and Nutraceutical Active Ingredients Using Electrospinning Processes.Nanomaterials (Basel). 2021 Jul 30;11(8):1968. doi: 10.3390/nano11081968. Nanomaterials (Basel). 2021. PMID: 34443799 Free PMC article. Review.
-
Immobilized nanoparticles-mediated enzyme therapy; promising way into clinical development.Discov Nano. 2023 Mar 23;18(1):55. doi: 10.1186/s11671-023-03823-7. Discov Nano. 2023. PMID: 37382752 Free PMC article. Review.
-
Impact of Additives on Drug Particles during Liquid Antisolvent Crystallization and Subsequent Freeze-Drying.Org Process Res Dev. 2023 Oct 6;27(11):2020-2034. doi: 10.1021/acs.oprd.3c00204. eCollection 2023 Nov 17. Org Process Res Dev. 2023. PMID: 38025987 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources